Cited 69 time in
Antimicrobial peptide-loaded gold nanoparticle-DNA aptamer conjugates as highly effective antibacterial therapeutics against Vibrio vulnificus
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Boeun | - |
| dc.contributor.author | Park, Jonggwan | - |
| dc.contributor.author | Ryu, Minkyung | - |
| dc.contributor.author | Kim, Soochan | - |
| dc.contributor.author | Joo, Minju | - |
| dc.contributor.author | Yeom, Ji-Hyun | - |
| dc.contributor.author | Kim, Suk | - |
| dc.contributor.author | Park, Yoonkyung | - |
| dc.contributor.author | Lee, Kangseok | - |
| dc.contributor.author | Bae, Jeehyeon | - |
| dc.date.accessioned | 2022-12-26T18:32:04Z | - |
| dc.date.available | 2022-12-26T18:32:04Z | - |
| dc.date.issued | 2017-10-19 | - |
| dc.identifier.issn | 2045-2322 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/13414 | - |
| dc.description.abstract | Vibrio vulnificus causes fatal infections in humans, and antibiotics are commonly used in treatment regimens against V. vulnificus infection. However, the therapeutic effects of antibiotics are limited by multidrug resistance. In this study, we demonstrated that an antimicrobial peptide (AMP), HPA3P(His), loaded onto a gold nanoparticle-DNA aptamer (AuNP-Apt) conjugate (AuNP-Apt-HPA3P(His)) is an effective therapeutic tool against V. vulnificus infection in vivo in mice. HPA3P(His) induced bacterial cell death through the disruption of membrane integrity of V. vulnificus. The introduction of AuNP-Apt-HPA3P(His) into V. vulnificus-infected HeLa cells dramatically reduced intracellular V. vulnificus by 90%, leading to an increase in the viability of the infected cells. Moreover, when V. vulnificus-infected mice were intravenously injected with AuNP-Apt-HPA3P(His), a complete inhibition of V. vulnificus colonization was observed in the mouse organs, leading to a 100% survival rate among the treated mice, whereas all the control mice died within 40 hours of being infected. Therefore, this study demonstrated the potential of an AMP delivered by AuNP-Apt as an effective and rapid treatment option against infection caused by a major pathogen in humans and aquatic animals. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | NATURE PUBLISHING GROUP | - |
| dc.title | Antimicrobial peptide-loaded gold nanoparticle-DNA aptamer conjugates as highly effective antibacterial therapeutics against Vibrio vulnificus | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1038/s41598-017-14127-z | - |
| dc.identifier.scopusid | 2-s2.0-85031907512 | - |
| dc.identifier.wosid | 000413191500011 | - |
| dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.7 | - |
| dc.citation.title | SCIENTIFIC REPORTS | - |
| dc.citation.volume | 7 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
| dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
| dc.subject.keywordPlus | IMMUNOMODULATORY FUNCTIONS | - |
| dc.subject.keywordPlus | DELIVERY | - |
| dc.subject.keywordPlus | INFECTION | - |
| dc.subject.keywordPlus | CYTOTOXICITY | - |
| dc.subject.keywordPlus | INSIGHTS | - |
| dc.subject.keywordPlus | EPINECIDIN-1 | - |
| dc.subject.keywordPlus | COMPOSITES | - |
| dc.subject.keywordPlus | MECHANISM | - |
| dc.subject.keywordPlus | HP-(2-20) | - |
| dc.subject.keywordPlus | MEMBRANE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
